Introduction: The effect of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism on risk of diabetic nephropathy (DN) is still conflicting. The present meta-analysis was performed to evaluate the overall risk of this polymorphism associated with DN in different groups.
Materials and methods: A predefined search was performed on 14,108 DN cases and 12,472 controls from 63 published studies by searching electronic databases and reference lists of relevant articles.
Results: In this meta-analysis, we found a significant association between the ACE I/D polymorphism and the risk of DN for all genetic models (ID versus II: odds ratio [OR] = 1.12, 95% confidence interval [CI] 1.02–1.24; DD versus II: OR = 1.27, 95% CI 1.13–1.44; allele contrast: OR = 1.15, 95% CI 1.08–1.23; dominant model: OR = 1.18, 95% CI 1.07–1.31; and recessive model: OR = 1.18, 95% CI 1.08–1.30, respectively). In stratified analysis by ethnicity and DM type, we further found that the Asian group with type 2 diabetes mellitus (T2DM) showed a significant association for all genetic models (ID versus II: OR = 1.25, 95% CI 1.07–1.47; DD versus II: OR = 1.57, 95% CI 1.24–1.98; allele contrast: OR = 1.30, 95% CI 1.15–1.46; dominant model: OR = 1.37, 95% CI 1.10–1.69; and recessive model: OR = 1.34, 95% CI 1.15–1.56, respectively).
Conclusions: Our study suggested that the ACE I/D polymorphism may contribute to DN development, especially in the Asian group with T2DM.
WangSMituGMHirschbergR. Osmotic polyuria: an overlooked mechanism in diabetic nephropathy. Nephrol Dial Transplant2008; 23: 2167–2172.
2.
RitzERychlikILocatelliFHalimiS. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis1999; 34: 795–808.
3.
AdlerAIStevensRJManleySEBilousRWCullCAHolmanRR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int2003; 63: 225–232.
4.
HovindPRossingPTarnowLSmidtUMParvingHH. Progression of diabetic nephropathy. Kidney Int2001; 59: 702–709.
5.
JacobsenPTarnowLCarstensenBHovindPPoirierOParvingHH. Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol2003; 14: 2843–2850.
6.
ParvingHHTarnowLRossingP. Genetics of diabetic nephropathy. J Am Soc Nephrol1996; 7: 2509–2517.
7.
Borch-JohnsenKNorgaardKHommelE. Is diabetic nephropathy an inherited complication?Kidney Int1992; 41: 719–722.
8.
QuinnMAngelicoMCWarramJHKrolewskiAS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia1996; 39: 940–945.
9.
StrojekKGrzeszczakWMorawinE. Nephropathy of type II diabetes: evidence for hereditary factors?Kidney Int1997; 51: 1602–1607.
10.
ZintzarasEStefanidisI. Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis. J Hum Genet2005; 50: 84–91.
11.
ZintzarasEUhligKKoukoulisGNPapathanasiouAAStefanidisI. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J Hum Genet2007; 52: 881–890.
12.
ShpichinetskyVRazIFriedlanderY. The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. J Nutr2000; 130: 2493–2497.
13.
SchmidtSRitzE. Genetics of the renin–angiotensin system and renal disease: a progress report. Curr Opin Nephrol Hypertens1997; 6: 146–151.
14.
BurnsKD. Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis2000; 36: 449–467.
15.
KimSIwaoH. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev2000; 52: 11–34.
16.
RudbergSAperiaAFreyschussUPerssonB. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia1990; 33: 470–476.
17.
TiretLRigatBVisvikisS. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet1992; 51: 197–205.
RigatBHubertCAlhenc-GelasFCambienFCorvolPSoubrierF. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest1990; 86: 1343–1346.
20.
DoriaAWarramJHKrolewskiAS. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I--converting enzyme gene. Diabetes1994; 43: 690–695.
21.
PowrieJKWattsGFInghamJNTaubNATalmudPJShawKM. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. BMJ1994; 309: 1608–1612.
22.
DudleyCRKeavneyBStrattonIMTurnerRCRatcliffePJ. U.K. Prospective Diabetes Study. XV: Relationship of renin–angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int1995; 48: 1907–1911.
23.
FujisawaTIkegamiHShenGQ. Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care1995; 18: 983–985.
24.
MizuiriSHemmiHInoueA. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron1995; 70: 455–459.
25.
PanagiotopoulosSSmithTJAldredGPBakerEJJacklinCJJerumsG. Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate. J Diabetes Complications1995; 9: 272–276.
26.
SchmidtSSchoneNRitzE. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int1995; 47: 1176–1181.
27.
TarnowLCambienFRossingP. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes1995; 44: 489–494.
28.
ChowdhuryTADronsfieldMJKumarS. Examination of two genetic polymorphisms within the renin–angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia1996; 39: 1108–1114.
29.
DoiYYoshizumiHYoshinariM. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia1996; 39: 97–102.
30.
NakajimaSBabaTYajimaY. Is ACE gene polymorphism a useful marker for diabetic albuminuria in Japanese NIDDM patients?Diabetes Care1996; 19: 1420–1422.
31.
OhTGShinCSParkKS. Relationships between angiotensin I converting enzyme gene polymorphism and renal complications in Korean IDDM patients. Korean J Intern Med1996; 11: 133–137.
32.
OhnoTKawazuSTomonoS. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism1996; 45: 218–222.
33.
YoshidaHKuriyamaSAtsumiY. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int1996; 50: 657–664.
34.
BarnasUSchmidtAIllievichA. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Diabetologia1997; 40: 327–331.
35.
HibberdMLMillwardBADemaineAG. The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type I diabetes. J Diabetes Complications1997; 11: 2–8.
36.
JeffersBWEstacioRORaynoldsMVSchrierRW. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int1997; 52: 473–477.
37.
MarreMJeunemaitreXGalloisY. Contribution of genetic polymorphism in the renin–angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest1997; 99: 1585–1595.
38.
RingelJBeigeJKunzRDistlerASharmaAM. Genetic variants of the renin–angiotensin system, diabetic nephropathy and hypertension. Diabetologia1997; 40: 193–199.
39.
DemurovLMChistiakovDAChugunovaLA. Polymorphism of the insertion/deletion type in the angiotensin-converting enzyme gene in normal subjects and among patients with vascular complications. Mol Biol (Mosk)1997; 31: 59–62.
40.
SchmidtSRitzE. Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes. Nephrol Dial Transplant1997; 12(Suppl. 2): 37–41.
41.
GutierrezCVendrellJPastorR. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. Metabolism1997; 46: 976–980.
42.
PfohlMFrostDKochM. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting-enzyme gene and diabetic nephropathy in IDDM patients. Horm Metab Res1998; 30: 276–280.
43.
FreireMBvan DijkDJErmanABonerGWarramJHKrolewskiAS. DNA polymorphisms in the ACE gene, serum ACE activity and the risk of nephropathy in insulin-dependent diabetes mellitus. Nephrol Dial Transplant1998; 13: 2553–2558.
44.
GrzeszczakWZychmaMJLackaBZukowska-SzczechowskaE. Angiotensin I-converting enzyme gene polymorphisms: relationship to nephropathy in patients with non-insulin dependent diabetes mellitus. J Am Soc Nephrol1998; 9: 1664–1669.
45.
HanyuOHanawaHNakagawaO. Polymorphism of the angiotensin I-converting enzyme gene in diabetic nephropathy in type II diabetic patients with proliferative retinopathy. Ren Fail1998; 20: 125–133.
46.
HuangXHRantalaihoVWirtaO. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years. Nephron1998; 80: 17–24.
47.
WuSXiangKWengQ. Relationship between angiotensin I converting enzyme gene polymorphism and diabetic nephropathy. Chin Med J (Engl)1998; 111: 478–479.
48.
BouhanickBGalloisYHadjadjSBouxdeCassonFLimalJMMarreM. Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents. Diabetes Care1999; 22: 618–622.
49.
De CosmoSMargaglioneMTassiV. ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes. Diabetes Metab Res Rev1999; 15: 247–253.
50.
KuramotoNIizukaTItoH. Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance. Am J Kidney Dis1999; 33: 276–281.
51.
MiuraJUchigataYYokoyamaHOmoriYIwamotoY. Genetic polymorphism of renin–angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus. Diabetes Res Clin Pract1999; 45: 41–49.
52.
VlemingLJvan der PijlJWLemkesHH. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM. Clin Nephrol1999; 51: 133–140.
53.
WongTYChanJCPoonELiPK. Lack of association of angiotensin-converting enzyme (DD/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes. Am J Kidney Dis1999; 33: 1064–1070.
54.
TominoYMakitaYShikeT. Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron1999; 82: 139–144.
55.
HsiehMCLinSRHsiehTJ. Increased frequency of angiotensin-converting enzyme DD genotype in patients with type 2 diabetes in Taiwan. Nephrol Dial Transplant2000; 15: 1008–1013.
56.
van IttersumFJde ManAMThijssenS. Genetic polymorphisms of the renin–angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant2000; 15: 1000–1007.
57.
ArazMYilmazNGungorKOkanVKepekciYSukru AynaciogluA. Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients. Diabetes Res Clin Pract2001; 54: 95–104.
58.
AzarSTZallouaPAMedlejRHalabiG. The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics. Endocr Res2001; 27: 99–108.
59.
GohdaTMakitaYShikeT. Association of the DD genotype and development of Japanese type 2 diabetic nephropathy. Clin Nephrol2001; 56: 475–480.
60.
TaniwakiHIshimuraEMatsumotoNEmotoMInabaMNishizawaY. Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy. Diabetes Care2001; 24: 1653–1660.
61.
ViswanathanVZhuYBalaK. Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients. JOP2001; 2: 83–87.
62.
FradinSGoulet-SalmonBChantepieM. Relationship between polymorphisms in the renin–angiotensin system and nephropathy in type 2 diabetic patients. Diabetes Metab2002; 28: 27–32.
63.
LeeYJTsaiJC. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care2002; 25: 1002–1008.
64.
HaSKParkHCParkHS. ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients: effect of ACE gene DD on the progression of diabetic nephropathy. Am J Kidney Dis2003; 41: 943–949.
65.
HadjadjSGalloisYAlhenc-GelasF. Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients. Diabet Med2003; 20: 677–682.
66.
OkunoSUtsugiTOhnoT. Angiotensin-converting enzyme gene polymorphism as a potent risk factor for developing microalbuminuria in Japanese patients with type 2 diabetes mellitus: a 9-year follow-up study. J Int Med Res2003; 31: 290–298.
67.
ChangHRChengCHShuKHChenCHLianJDWuMY. Study of the polymorphism of angiotensinogen, angiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan. J Chin Med Assoc2003; 66: 51–56.
68.
Arzu ErgenHHatemiHAgachanBCamlicaHIsbirT. Angiotensin-I converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Exp Mol Med2004; 36: 345–350.
69.
ParkHCChoiSRKimBS. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients. Yonsei Med J2005; 46: 779–787.
70.
CananiLHCostaLACrispimD. The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes. Diabet Med2005; 22: 1167–1172.
71.
PrasadPTiwariAKKumarKM. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet2006; 7: 42.
72.
BuraczynskaMKsiazekPDropAZaluskaWSpasiewiczDKsiazekA. Genetic polymorphisms of the renin–angiotensin system in end-stage renal disease. Nephrol Dial Transplant2006; 21: 979–983.
73.
SoWYMaRCOzakiR. Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients– interaction with ACE insertion/deletion polymorphism. Kidney Int2006; 69: 1438–1443.
74.
OsawaNKoyaDArakiS. Combinational effect of genes for the renin–angiotensin system in conferring susceptibility to diabetic nephropathy. J Hum Genet2007; 52: 143–151.
75.
HadjadjSTarnowLForsblomC. Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control, haplotype, and family-based study in three European populations. J Am Soc Nephrol2007; 18: 1284–1291.
76.
MovvaSAlluriRVKomandurS. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians. J Diabetes Complications2007; 21: 237–241.
77.
MollstenAKockumISvenssonM. The effect of polymorphisms in the renin–angiotensin-aldosterone system on diabetic nephropathy risk. J Diabetes Complications2008; 22: 377–383.
78.
GallegoPHShephardNBulsaraMK. Angiotensinogen gene T235 variant: a marker for the development of persistent microalbuminuria in children and adolescents with type 1 diabetes mellitus. J Diabetes Complications2008; 22: 191–198.
79.
ErogluZCetinkalpSErdoganM. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy. J Diabetes Complications2008; 22: 186–190.
80.
TienKJHsiaoJYHsuSC. Gender-dependent effect of ACE I/D and AGT M235T polymorphisms on the progression of urinary albumin excretion in Taiwanese with type 2 diabetes. Am J Nephrol2009; 29: 299–308.
81.
AhluwaliaTSAhujaMRaiTS. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol2009; 28: 141–150.
82.
JayapalanJJMuniandySChanSP. Null association between ACE gene I/D polymorphism and diabetic nephropathy among multiethnic Malaysian subjects. Indian J Hum Genet16: 78–86.
83.
ZintzarasELauJ. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol2008; 61: 634–645.
84.
HigginsJPThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med2002; 21: 1539–1558.
85.
EggerMDavey SmithGSchneiderMMinderC. Bias in meta-analysis detected by a simple, graphical test. BMJ1997; 315: 629–634.
86.
BeggCBMazumdarM. Operating characteristics of a rank correlation test for publication bias. Biometrics1994; 50: 1088–1101.
87.
Harrison-BernardLM. The renal renin–angiotensin system. Adv Physiol Educ2009; 33: 270–274.
88.
BrennerBMCooperMEde ZeeuwD. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med2001; 345: 861–869.
89.
LewisEJHunsickerLGBainRPRohdeRD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med1993; 329: 1456–1462.
90.
SmithCWPorroEBPattonJGNadal-GinardB. Scanning from an independently specified branch point defines the 3’ splice site of mammalian introns. Nature1989; 342: 243–247.
91.
DanserAHSchalekampMABaxWA. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation1995; 92: 1387–1388.
92.
TarnowLGluudCParvingHH. Diabetic nephropathy and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Nephrol Dial Transplant1998; 13: 1125–1130.
93.
KunzRBorkJPFritscheLRingelJSharmaAM. Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. J Am Soc Nephrol1998; 9: 1653–1663.
94.
NgDPTaiBCKohDTanKWChiaKS. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia2005; 48: 1008–1016.
95.
EggerMZellweger-ZahnerTSchneiderMJunkerCLengelerCAntesG. Language bias in randomised controlled trials published in English and German. Lancet1997; 350: 326–329.
96.
PassaroACalzoniFVolpatoS. Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up. J Intern Med2003; 254: 264–271.
97.
MaJStampferMJGiovannucciE. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res1997; 57: 1098–1102.
